These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33221183)

  • 1. Microvascular breast reconstruction and thromboembolic events in patients on hormone therapy: Audit of practice from a tertiary referral centre.
    Samaras S; Ashfield S; Ali SF; Fopp LJ; Benson JR; Malata CM
    J Plast Reconstr Aesthet Surg; 2021 May; 74(5):957-965. PubMed ID: 33221183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?
    Jokuszies A; Radtke C; Betzler C; Branski L; Krämer R; Vogt PM
    Ger Med Sci; 2013; 11():Doc05. PubMed ID: 23423877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Perioperative Tamoxifen Therapy on Microvascular Flap Complications in Transverse Rectus Abdominis Myocutaneous/Deep Inferior Epigastric Perforator Flap Breast Reconstruction.
    Salibian AA; Bokarius AV; Gu J; Lee Y; Wirth GA; Paydar KZ; Kobayashi MR; Evans GR
    Ann Plast Surg; 2016 Dec; 77(6):630-634. PubMed ID: 26808759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis.
    Parikh RP; Odom EB; Yu L; Colditz GA; Myckatyn TM
    Breast Cancer Res Treat; 2017 May; 163(1):1-10. PubMed ID: 28185144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based Microsurgical Breast Reconstruction?
    Tran BNN; Ruan QZ; Cohen JB; Kamali P; Doval AF; Tobias AM; Singhal D; Lin SJ; Lee BT
    Plast Reconstr Surg; 2018 Jun; 141(6):805e-813e. PubMed ID: 29794694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of perioperative hormonal breast cancer therapy for microvascular flap complications in breast reconstruction.
    Mahrhofer M; Reichert R; Siegwart LC; Russe E; Schoeller T; Wechselberger G; Weitgasser L
    J Plast Reconstr Aesthet Surg; 2023 Oct; 85():143-148. PubMed ID: 37487260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
    Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
    J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as potential perioperative thrombotic risk factors in free flap breast reconstruction.
    Mirzabeigi MN; Nelson JA; Fischer JP; Kovach SJ; Serletti JM; Wu LC; Kanchwala S
    Plast Reconstr Surg; 2015 Apr; 135(4):670e-679e. PubMed ID: 25811579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction.
    Billon R; Bosc R; Belkacemi Y; Assaf E; SidAhmed-Mezi M; Hersant B; Meningaud JP
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1495-1504. PubMed ID: 28676319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.
    Kelley BP; Valero V; Yi M; Kronowitz SJ
    Plast Reconstr Surg; 2012 Feb; 129(2):305-314. PubMed ID: 21987043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.
    Eisen A; Trudeau M; Shelley W; Messersmith H; Pritchard KI
    Cancer Treat Rev; 2008 Apr; 34(2):157-74. PubMed ID: 18164821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
    Perez EA
    Ann Oncol; 2007 Sep; 18 Suppl 8():viii26-35. PubMed ID: 17890211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.
    Buzdar A
    Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S42-8. PubMed ID: 12756078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
    Spicer J; Ellis P
    Cancer Lett; 2007 Apr; 248(2):165-74. PubMed ID: 16919870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
    Gradishar WJ
    Oncology; 2005; 69(1):1-9. PubMed ID: 16088229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant aromatase inhibitors following tamoxifen for early-stage breast cancer in postmenopausal women: what do we really know?
    Chung CT; Carlson RW
    Clin Breast Cancer; 2004 Sep; 5 Suppl 1():S18-23. PubMed ID: 15347435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Use of Antiestrogen Therapies in Breast Reconstruction: A Systematic Review and Treatment Recommendations.
    Spera LJ; Cook JA; Dolejs S; Fisher C; Lester ME; Hassanein AH
    Ann Plast Surg; 2020 Oct; 85(4):448-455. PubMed ID: 32332390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.